|
Oct 10
|
Codexis to Report Third Quarter 2024 Financial Results on October 31
|
|
Oct 9
|
Codexis Inc (CDXS) Q2 2024 Earnings Call Highlights: Navigating Revenue Challenges and ...
|
|
Oct 1
|
Codexis Licenses Genomics Life Science Enzyme Portfolio to Alphazyme LLC, part of Maravai LifeSciences
|
|
Sep 7
|
Pleasing Signs As A Number Of Insiders Buy Codexis Stock
|
|
Sep 6
|
Codexis Announces New Employment Inducement Grants
|
|
Jun 24
|
Investors in Codexis (NASDAQ:CDXS) have unfortunately lost 88% over the last three years
|
|
Jun 12
|
Syntis Bio launches oral therapies for metabolic diseases
|
|
May 22
|
Codexis to Participate in Jefferies Global Healthcare Conference
|
|
May 20
|
Codexis to Participate in TD Cowen 2nd Annual Sustainability Week
|
|
May 14
|
Codexis Presents Groundbreaking Enzymatic Synthesis Data at TIDES USA Annual Meeting
|
|
May 4
|
Codexis First Quarter 2024 Earnings: Beats Expectations
|
|
May 3
|
Codexis, Inc. (NASDAQ:CDXS) Q1 2024 Earnings Call Transcript
|
|
May 3
|
Q1 2024 Codexis Inc Earnings Call
|
|
May 3
|
Codexis Inc (CDXS) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and ...
|
|
May 2
|
Codexis Inc (CDXS) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Advances
|
|
May 2
|
Codexis Reports First Quarter 2024 Financial Results
|
|
Apr 26
|
With 74% institutional ownership, Codexis, Inc. (NASDAQ:CDXS) is a favorite amongst the big guns
|
|
Apr 18
|
Codexis to Report First Quarter 2024 Financial Results on May 2
|
|
Apr 11
|
Codexis Appoints Carole Cobb, MBA, to Strategic Advisory Board
|
|
Mar 30
|
Favourable Signals For Codexis: Numerous Insiders Acquired Stock
|